The researchers observed variation in the absolute risk for neonatal drug withdrawal from 1.0 to 11.4% for infants exposed in utero to prescription opioids alone and opioids co-prescribed with gabapentin, respectively.
If two or more consecutive doses include the affected product, therapeutic levels may not be maintained and may result in a resurgence of symptoms.
Analysis showed that safety events were significantly more frequent among biologics, psychiatric treatments, treatments with accelerated approval, and near-regulatory deadline approval.
According to the adjusted results from a recent study, second generation antipsychotic long-acting injectable medications were linked to consistently more adherence and persistence when compared to oral antipsychotic patients.
The gradual trend toward recommending lower dosages of chlorpromazine has arisen not due to trial based evidence, but rather clinical experience and consensus.
We examined whether mental and behavioral disorders in general or specific mental and behavioral disorder categories increase the risk of Alzheimer's disease.
Results showed that the investigated psychotherapies were moderately more effective—as assessed by standardized mean differences (Hedges g)—in terms of borderline symptoms, self-harm and suicide than control interventions.
The review found no statistically significant difference between the two groups regarding adherence and treatment response.
The patient presented with complaints of increased muscle tone in her back muscles and the right side of her body starting in adolescence.
Allergan announced that the Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Vraylar (cariprazine) for the addition of new data evaluating Vraylar for the maintenance of efficacy in adults with schizophrenia.
A total of 186 studies of patients who sought help for mental health conditions were analyzed, overall, the average treatment refusal rate was 8.2%.
The FDA has approved updates to all antipsychotic medication labels to specifically warn of somnolence, postural hypotension, and motor and sensory instability risks.
Sunovion announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Latuda (lurasidone HCl) for the treatment of schizophrenia in adolescents aged 13-17 years.
Based on Phase 2 studies, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy could be a potential treatment option for several psychiatric conditions, however turning this controlled substance into a therapeutic agent is contingent upon successful Phase 3 trials and regulatory approval.
According to a study published in JAMA Psychiatry, the use of antipsychotics was associated with an increased risk of acute respiratory failure in patients with chronic obstructive pulmonary disease (COPD).
The Food and Drug Administration (FDA) has announced that the full launch for the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program will be postponed due to recent technical and logistical challenges.
One in six U.S. adults take a psychiatric medication to treat conditions such as depression, anxiety, and insomnia, according to a study published online in JAMA Internal Medicine.
About 4% of U.S. teens surveyed admit to trying the "choking game," a potentially deadly game of temporary strangulation, and young people who play the game alone are much more likely to harbor thoughts of suicide
Patients who had repeated use of intramuscular (IM) antipsychotics experienced a significantly longer length of stay (LOS) in the emergency department (ED) vs. non-repeat users of IM antipsychotics, according to a new study published in Journal of Psychiatric Practice.
Sunovion has announced positive results from a study evaluating Latuda (lurasidone HCI) for the treatment of schizophrenia in adolescents aged 13 to 17 years old.
Young men with a resting heart rate and blood pressure that are elevated - but still within normal range - appear more likely to develop a wide range of mental illnesses later in their lives, according to a study published online in JAMA Psychiatry.